| Dr Kimberly Blake, MD | |
|
96 Colchester Ave, Burlington, VT 05401-1417 | |
| (802) 658-0505 | |
| Not Available |
| Full Name | Dr Kimberly Blake |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 34 Years |
| Location | 96 Colchester Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265480222 | NPI | - | NPPES |
| 160050512 | Other | VT | RAIL ROAD MEDICARE |
| 0VN0812 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0420008805 (Vermont) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 302048 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.
The active promotion of immediate treatment after suspected HIV transmission to minimise the risk of infection may be doing more harm than good, claim senior doctors in Sexually Transmitted Infections.
This weekend, hundreds of home care and hospice providers arrive in Washington, DC, for the National Association for Home Care & Hospice March on Washington taking place March 22-25, 2015. NAHC's conference will raise awareness of key policy issues impacting providers and their ability to care for the growing number of Americans who rely on home health.
A new study suggests that most people with acute conjunctivitis, or pink eye, are getting the wrong treatment. About 60 percent of patients are prescribed antibiotic eyedrops, even though antibiotics are rarely necessary to treat this common eye infection.
Results from a clinical trial presented at the American Society of Hematology 46th Annual Meeting and Exposition (ASH) demonstrated that Zevalin (ibritumomab tiuxetan), administered as a first-line therapy, induced a 100 percent response rate in a small population of patients with low-grate follicular lymphoma (FL).
› Verified 7 days ago
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.
The active promotion of immediate treatment after suspected HIV transmission to minimise the risk of infection may be doing more harm than good, claim senior doctors in Sexually Transmitted Infections.
This weekend, hundreds of home care and hospice providers arrive in Washington, DC, for the National Association for Home Care & Hospice March on Washington taking place March 22-25, 2015. NAHC's conference will raise awareness of key policy issues impacting providers and their ability to care for the growing number of Americans who rely on home health.
A new study suggests that most people with acute conjunctivitis, or pink eye, are getting the wrong treatment. About 60 percent of patients are prescribed antibiotic eyedrops, even though antibiotics are rarely necessary to treat this common eye infection.
Results from a clinical trial presented at the American Society of Hematology 46th Annual Meeting and Exposition (ASH) demonstrated that Zevalin (ibritumomab tiuxetan), administered as a first-line therapy, induced a 100 percent response rate in a small population of patients with low-grate follicular lymphoma (FL).
› Verified 7 days ago
| Entity Name | Affiliates In Obstetrical & Gynecological Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104884824 PECOS PAC ID: 0244318699 Enrollment ID: O20080424000755 |
News Archive
Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.
The active promotion of immediate treatment after suspected HIV transmission to minimise the risk of infection may be doing more harm than good, claim senior doctors in Sexually Transmitted Infections.
This weekend, hundreds of home care and hospice providers arrive in Washington, DC, for the National Association for Home Care & Hospice March on Washington taking place March 22-25, 2015. NAHC's conference will raise awareness of key policy issues impacting providers and their ability to care for the growing number of Americans who rely on home health.
A new study suggests that most people with acute conjunctivitis, or pink eye, are getting the wrong treatment. About 60 percent of patients are prescribed antibiotic eyedrops, even though antibiotics are rarely necessary to treat this common eye infection.
Results from a clinical trial presented at the American Society of Hematology 46th Annual Meeting and Exposition (ASH) demonstrated that Zevalin (ibritumomab tiuxetan), administered as a first-line therapy, induced a 100 percent response rate in a small population of patients with low-grate follicular lymphoma (FL).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kimberly Blake, MD 96 Colchester Ave, Burlington, VT 05401-1417 Ph: (802) 658-0505 | Dr Kimberly Blake, MD 96 Colchester Ave, Burlington, VT 05401-1417 Ph: (802) 658-0505 |
News Archive
Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.
The active promotion of immediate treatment after suspected HIV transmission to minimise the risk of infection may be doing more harm than good, claim senior doctors in Sexually Transmitted Infections.
This weekend, hundreds of home care and hospice providers arrive in Washington, DC, for the National Association for Home Care & Hospice March on Washington taking place March 22-25, 2015. NAHC's conference will raise awareness of key policy issues impacting providers and their ability to care for the growing number of Americans who rely on home health.
A new study suggests that most people with acute conjunctivitis, or pink eye, are getting the wrong treatment. About 60 percent of patients are prescribed antibiotic eyedrops, even though antibiotics are rarely necessary to treat this common eye infection.
Results from a clinical trial presented at the American Society of Hematology 46th Annual Meeting and Exposition (ASH) demonstrated that Zevalin (ibritumomab tiuxetan), administered as a first-line therapy, induced a 100 percent response rate in a small population of patients with low-grate follicular lymphoma (FL).
› Verified 7 days ago
Dr. Ira Mark Bernstein, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Department Of Obstetrics And Gynceology, Burlington, VT 05401 Phone: 802-847-5066 Fax: 802-847-2772 | |
Dr. Eleanor Lacava Capeless, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Fahc, Acc 4th Floor, Burlington, VT 05401 Phone: 802-847-5066 | |
Dr. Renju S Raj, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-3450 | |
Charles Warner Ashley, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-5110 | |
Dr. Alexandra Charlotte Fenton, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 96 Colchester Ave, Burlington, VT 05401 Phone: 802-658-0505 | |
Justin A. Deangelis, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-1400 Fax: 802-847-8433 | |
Dr. Adam Buckley, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-8181 |